Viewing Study NCT01512667


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2025-12-25 @ 10:34 PM
Study NCT ID: NCT01512667
Status: COMPLETED
Last Update Posted: 2018-08-28
First Post: 2012-01-13
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)
Sponsor: Merck Sharp & Dohme LLC
Organization: